Here's what you should know
In adults with type 2 diabetes and established heart disease, it is also approved to reduce the risk of major cardiovascular events such as heart attack, stroke, and cardiovascular death
I couldnt find a specific reason for it being denied by Health Canada but I suspect it is due to Phentermines history with Fen-Phen
The correlation data of plasma ANGPTL5 levels in the subjects with type II diabetes and obesity suggest the roles in lipid and glucose metabolism, obesity, and diabetes mellitus (Liu et al., 2021
This glucose-dependent potentiation of insulin secretion is severely impaired in patients with type-2 diabetes mellitus
Semaglutide (Ozempic): An initial dose of 0.25 mg is administered subcutaneously on a weekly basis for the first month, which is then increased to 0.5 mg weekly